Qing Hao

机构：Swarthmore College, Hubei University of Medicine, Harbin Medical University, Second Affiliated Hospital of Harbin Medical University · ORCID：0000-0002-1097-893X

发表论文 125 篇 · 总被引 3937 次 · h-index 32

代表论文

• Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment (2025 · Signal Transduction and Targeted Therapy · 被引 58)
• Development and Clinical Applications of Therapeutic Cancer Vaccines with Individualized and Shared Neoantigens (2024 · Vaccines · 被引 20)
• Clinical efficacy and immune response of neoadjuvant camrelizumab plus chemotherapy in resectable locally advanced oesophageal squamous cell carcinoma: a phase 2 trial (2024 · British Journal of Cancer · 被引 17)
• Dynamics of The Γδtcr Repertoires During The Dedifferentiation Process and Pilot Implications for Immunotherapy of Thyroid Cancer (2024 · Advanced Science · 被引 7)
• Effects of miR-214 on adenosine A2A receptor and carboxymethyl chitosan nanoparticles on the function of keloid fibroblasts and their mechanisms (2024 · Scientific Reports · 被引 3)
• Characterization of the novel HLA‐DRB1*16:76 allele in a Chinese individual (2024 · HLA · 被引 3)